Life
What this AI epitope library means for vaccines, immunotherapy and biosensors
Strategic angle: A new tool makes it possible to screen millions of tiny protein fragments and select those that can be recognized by the immune system.
editorial-staff
1 min read
Updated 3 days ago
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has introduced a novel system named epiGPTope, aimed at advancing vaccine and immunotherapy research.
This innovative tool facilitates the screening of millions of tiny protein fragments, allowing researchers to pinpoint those that can be effectively recognized by the immune system.
The implications of this technology extend to the development of more targeted biosensors, potentially improving diagnostic and therapeutic strategies in immunology.